Screener
Ironwood Pharmaceuticals IRWD Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | 60.1%+36.4pp | 55.4%+38.7pp | 33.3%+6.8pp | 36.3%+20.1pp | 23.8%+4.8pp | |
| Net margin | 33.4%+35.9pp | 28.3%+38.4pp | 8.1%+7.9pp | 8.4%+9.1pp | -2.6%-4.9pp | |
| Efficiency | ||||||
| Asset turnover | 1.2×+0.4× | 0.9×+0.1× | 0.8×-0.1× | 0.9×0.0× | 0.8×0.0× | |
| Liquidity | ||||||
| Current ratio | 6.1×+5.2× | 1.4×-1.9× | 1.1×-3.6× | 1.1×-2.5× | 0.8×-3.1× | |
| Leverage | ||||||
| Net debt / EBITDA | -0.3×-1.9× | -0×+1.7× | -0×+0.7× | 0.6×+1.7× | 1.6×+2.8× | |
| Per Share | ||||||
| Book value per share | -$0.97+44.4% | -$1.30+37.2% | -$1.61+14.7% | -$1.49+23.5% | -$1.74+13.9% | |
| Valuation | ||||||
| Market capitalization | $713.84M+427% | $572.33M+143% | $548.23M-22.7% | $212.79M-67.5% | $117.45M-88.6% | |
| Price / earnings | 5.5×— | 5.6×— | 22.8×-783× | 7.5×— | —— | |
| Price / sales | 1.8×+1.4× | 1.6×+0.8× | 1.9×-0.2× | 0.6×-1.1× | 0.4×-2.2× | |
| EV / EBITDA | 2.7×-0.7× | 2.8×+0.2× | 5.4×-1.3× | 2.3×-7.0× | 3.2×-9.0× |
FAQ
- What are Ironwood Pharmaceuticals's profit margins?
- Ironwood Pharmaceuticals (IRWD) runs a 99.2% gross margin and a 60.1% operating margin, with a 33.4% net margin.
- Where do Ironwood Pharmaceuticals's ratios come from?
- Every ratio is computed from Ironwood Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
